<DOC>
	<DOCNO>NCT00505388</DOCNO>
	<brief_summary>This patient follow-up programme design describe extent Symbicort use patient prescribed Symbicort maintenance reliever therapy routine clinical practice comparison already document use Symbicort maintenance reliever therapy clinical therapy</brief_summary>
	<brief_title>A Follow-up Programme Patients Using Symbicort SMART Normal Clinical Practice</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Budesonide , Formoterol Fumarate Drug Combination</mesh_term>
	<criteria>Asthma patient prescribe Symbicort maintenance reliever therapy , accord label , inclusion programme sign date informed consent ( ICF ) patient underage , sign date ICF form patient patient 's parent/legal guardian require Involvement plan conduct programme ( applies AstraZeneca staff staff investigational site )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>asthma</keyword>
	<keyword>bronchial</keyword>
	<keyword>Symbicort</keyword>
</DOC>